Abstract
Asymmetric and rapidly progressive painful sensorimotor disturbances raise concern for vasculitic neuropathy, the most common cause of which is non-systemic vasculitic neuropathy (NSVN). Nerve damage occurs by ischemic injury via mechanisms that differ between each process. The diagnosis is confirmed by history, examination, electrodiagnostic studies, laboratory findings, and likely nerve/muscle biopsy. Treatment is dependent on the underlying cause, and diagnosis is focused on evaluation for systemic vasculitides that can result in significant morbidity. In the case of NSVN, corticosteroids and consideration of other immunosuppressants are necessary to avoid further injury and disability.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsChange history
26 November 2020
Chapter 32 in T. Malik (ed.), Practical Chronic Pain Management, https://doi.org/10.1007/978-3-030-46675-6_32
References
Reife MD, Coulis CM. Peroneal neuropathy misdiagnosed as L5 radiculopathy: a case report. Chiropr Man Therap. 2013;21(1):12.
Collins MP, Periquet MI. Isolated vasculitis of the peripheral nervous system. Clin Exp Rheumatol. 2008;26(3):S118–30.
Kararizou E, Davaki P, Karandreas N, Davou R, Vassilopoulos D. Nonsystemic vasculitic neuropathy: a clinicopathological study of 22 cases. J Rheumatol. 2005;32(5):853–8.
Bennett DL, Groves M, Blake J, Holton JL, King RHM, Orrell RW, et al. The use of nerve and muscle biopsy in the diagnosis of vasculitis: a 5 year retrospective study. J Neurol Neurosurg Psychiatry. 2008;79(12):1376–81.
Collins MP, Arnold WD, Kissel JT. The neuropathies of vasculitis. Neurol Clin. 2013;31(2):557–95.
Takahashi M, Koike H, Ikeda S, Kawagashira Y, Iijima M, Hashizume A, et al. Distinct pathogenesis in nonsystemic vasculitic neuropathy and microscopic polyangiitis. Neurol Neuroimmunol Neuroinflamm. 2017;4(6):e407.
Morozumi S, Koike H, Tomita M, Kawagashira Y, Iijima M, Katsuno M, et al. Spatial distribution of nerve fiber pathology and vasculitis in microscopic polyangiitis-associated neuropathy. J Neuropathol Exp Neurol. 2011;70(5):340–8.
Ntatsaki E, Carruthers D, Chakravarty K, D'Cruz D, Harper L, Jayne D, et al. BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis. Rheumatology (Oxford). 2014;53(12):2306–9.
Waldfogel JM, Nesbit SA, Dy SM, Sharma R, Zhang A, Wilson LM, et al. Pharmacotherapy for diabetic peripheral neuropathy pain and quality of life: a systematic review. Neurology. 2017;88(20):1958–67.
Bril V, England J, Franklin GM, Backonja M, Cohen J, Del Toro D, et al. Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. PM R. 2011;3(4):345–52, 52.e1–21.
Attal N, Cruccu G, Baron R, Haanpaa M, Hansson P, Jensen TS, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010;17(9):1113–e88.
De Vita S, Quartuccio L, Fabris M. Rituximab in mixed cryoglobulinemia: increased experience and perspectives. Dig Liver Dis. 2007;39:S122–8.
Collins MP, Hadden RD. The nonsystemic vasculitic neuropathies. Nat Rev Neurol. 2017;13(5):302–16.
Collins MP, Periquet MI, Mendell JR, Sahenk Z, Nagaraja HN, Kissel JT. Nonsystemic vasculitic neuropathy: insights from a clinical cohort. Neurology. 2003;61(5):623–30.
Uceyler N, Geng A, Reiners K, Toyka KV, Sommer C. Non-systemic vasculitic neuropathy: single-center follow-up of 60 patients. J Neurol. 2015;262(9):2092–100.
Gonzalez-Gay MA, Garcia-Porrua C. Systemic vasculitis in adults in northwestern Spain, 1988-1997. Clinical and epidemiologic aspects. Medicine (Baltimore). 1999;78(5):292–308.
Mahr A, Guillevin L, Poissonnet M, Ayme S. Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener’s granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis Rheum. 2004;51(1):92–9.
Pagnoux C, Seror R, Henegar C, Mahr A, Cohen P, Le Guern V, et al. Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database. Arthritis Rheum. 2010;62(2):616–26.
Terrier B, Lacroix C, Guillevin L, Hatron PY, Dhote R, Maillot F, et al. Diagnostic and prognostic relevance of neuromuscular biopsy in primary Sjogren's syndrome-related neuropathy. Arthritis Rheum. 2007;57(8):1520–9.
Zivkovic SA, Ascherman D, Lacomis D. Vasculitic neuropathy – electrodiagnostic findings and association with malignancies. Acta Neurol Scand. 2007;115(6):432–6.
Deprez M, de Groote CC, Gollogly L, Reznik M, Martin JJ. Clinical and neuropathological parameters affecting the diagnostic yield of nerve biopsy. Neuromuscul Disord. 2000;10(2):92–8.
Lindenlaub T, Sommer C. Cytokines in sural nerve biopsies from inflammatory and non-inflammatory neuropathies. Acta Neuropathol. 2003;105(6):593–602.
Vrancken AF, Notermans NC, Jansen GH, Wokke JH, Said G. Progressive idiopathic axonal neuropathy – a comparative clinical and histopathological study with vasculitic neuropathy. J Neurol. 2004;251(3):269–78.
Collins MP, Dyck PJ, Gronseth GS, Guillevin L, Hadden RD, Heuss D, et al. Peripheral nerve society guideline on the classification, diagnosis, investigation, and immunosuppressive therapy of non-systemic vasculitic neuropathy: executive summary. J Periph Nerv Syst. 2010;15(3):176–84.
Collins MP, Mendell JR, Periquet MI, Sahenk Z, Amato AA, Gronseth GS, et al. Superficial peroneal nerve/peroneus brevis muscle biopsy in vasculitic neuropathy. Neurology. 2000;55(5):636–43.
Rappaport WD, Valente J, Hunter GC, Rance NE, Lick S, Lewis T, et al. Clinical utilization and complications of sural nerve biopsy. Am J Surg. 1993;166(3):252–6.
Hadden RDM, Collins MP, Zivkovic SA, Hsieh ST, Bonetto C, Felicetti P, et al. Vasculitic peripheral neuropathy: case definition and guidelines for collection, analysis, and presentation of immunisation safety data. Vaccine. 2017;35(11):1567–78.
Vrancken AF, Hughes RA, Said G, Wokke JH, Notermans NC. Immunosuppressive treatment for non-systemic vasculitic neuropathy. Cochrane Database Syst Rev. 2007;(24):1.
Pollard JD, McLeod JG, Spies JM, Davies L. Vasculitis confined to peripheral nerves. Brain. 1996;119(5):1441–8.
Collins MP. The vasculitic neuropathies: an update. Curr Opin Neurol. 2012;25(5):573–85.
Gwathmey KG, Burns TM, Collins MP, Dyck PJ. Vasculitic neuropathies. Lancet Neurol. 2014;13(1):67–82.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Fuino, R., Tandan, R., Waheed, W. (2020). 45-Year-Old Man with Leg Pain and Numbness. In: Malik, T. (eds) Practical Chronic Pain Management. Springer, Cham. https://doi.org/10.1007/978-3-030-46675-6_32
Download citation
DOI: https://doi.org/10.1007/978-3-030-46675-6_32
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-46674-9
Online ISBN: 978-3-030-46675-6
eBook Packages: MedicineMedicine (R0)